PETNECK 2

Offical account of the NIHR funded PETNECK 2 programme - investigating alternative follow up strategies for head and neck cancer patients

[PETNECK 2 @PETNECK2]

Recruitment successfully completed - a key milestone achieved!

A huge thanks to our NHS sites and research teams for their outstanding dedication and hard work and deeply grateful to the patients who chose to take part.

Onwards to the next Phase!

[PETNECK 2 @PETNECK2]

New paper alert!
We explored how acceptable patient‑initiated follow‑up (PIFU) is for people treated for head & neck cancer — and how a tailored support package can empower patients in self‑management.
Published in BMJ Open https://t.co/2adIiz7FwL
👇

[PETNECK 2 @PETNECK2]

not long to go....700 patients now randomised! Fantastic work by all our recruiting NHS sites. Thank you.

[@swallowsgroup @swallowsgroup]

Please support our petition sign and share https://t.co/TD60G7HrYj

[PETNECK 2 @PETNECK2]

It has been a fantastic year! The PETNECK2 team would like to thank you for all your hard work and support. Merry Christmas and Happy Holidays!

[PETNECK 2 @PETNECK2]

We are getting closer to our target. Let's keep the momentum going!

[Dr Lauren Matheson @dr_matheson]

New Head and Neck cancer study: We are creating a new information and support resource to help people through the difficult weeks after treatment - and we need your help. Contact us: https://t.co/S5WzksV4ZF

[PETNECK 2 @PETNECK2]

We are getting there!

[PETNECK 2 @PETNECK2]

@tlrobinson41 @Leic_hospital @NIHRresearch Congratulations Tracy! It is wonderful to have you on the PETNECK2 team. Many thanks for your hard work and support!

[PETNECK 2 @PETNECK2]

Starting 2025 with good news! We have randomised our 400th patient. Congratulations to @RichWi11iams and the team at @Derriford_Hosp.

452 patients are now registered into @PETNECK2 trial so a big thank you to all our recruiting sites! Please keep your efforts going.

[Gözde Özakıncı @Gozde786]

So pleased to see that @CurrentOncology made our paper the cover of the latest issue https://t.co/3UocXblku4. See our paper https://t.co/CDNwsDHIgj Fear of Cancer Recurrence and Fear of Cancer Progression, Digital Resource Engagement and Health Literacy: A Review @PETNECK2

[Ahmad k. Abou-Foul @AKAbouFoul]

@NIHRresearch @InhanseResearch @Janine_dretzke

#Oncology
#Prediction

https://t.co/1ci1RnQWww

https://t.co/4JSlWHRezd

[Gözde Özakıncı @Gozde786]

Fear of Cancer Recurrence and Fear of Cancer Progression, Digital Resource Engagement and Health Literacy: A Review https://t.co/wZoUocWLN5 #mdpicurroncol via @CurrentOncology @PETNECK2 @PaulNankivell very proud of Maebh who took the lead in this paper!

[Ahmad k. Abou-Foul @AKAbouFoul]

Our recent publications from the @PETNeck2 programme spotlight critical gaps in predictive modelling for Head & Neck cancers, marked by high bias and underwhelming performance. Surprisingly, ML/AI remains vastly underutilized in this space! Links below👇@PaulNankivell @h_mehanna

[PETNECK 2 @PETNECK2]

And we hit our 400th registration into the
@PETNECK2 trial! A massive thank you to our recruiting sites for their hard work and support....Let's accelerate our recruitment...calling out for at least 1 patient a month per site, more the merrier !

[PETNECK 2 @PETNECK2]

Congratulations to the Freeman Hospital team for randomising the 300th patients in the @PETNECK2 trial.

349 patients have registered to the study. A massive thanks to all our NHS staff and patients for their ongoing support.

[ISRCTN: the UK's Clinical Study Registry @ISRCTN]

PET-CT-guided, symptom-based, patient-initiated surveillance versus clinical follow-up in head neck cancer patients

Read the @PETNECK2 protocol in #BMCCancer @BMC_Series

#ISRCTN: https://t.co/o0sXyx5rcY

https://t.co/3goaS1rn6k

[PETNECK 2 @PETNECK2]

Delighted to announce that the Protocol for the @
@Petneck2 trial is now published in BMC Cancer
@BMC_series. The trial is open across 31 sites and has recruited 293 patients! @PaulNankivell, @h_mehanna,
@CRCTU

https://t.co/GmOd9PJUsv

[InHANSE RESEARCH @InhanseResearch]

We are delighted to announce that Prof Hisham Mehanna has been elected to the Fellowship of the Academy of Medical Sciences. Congrats Hisham FMedSci!! @unibirm_MDS

[PETNECK 2 @PETNECK2]

Congratulations to Derriford hospital @RDInUHP for randomising the 200th patient to @Petneck2 Trial. 240 patients are currently taking part in this practice-changing trial. Thank you to all our recruiting NHS sites and trial participants. Your support is greatly appreciated!